Advertisement

InMode Ltd. INMD

Set alert

Price alert · INMD

All alert types
13.22 USD -0.29 -2.15%

At close · Oct 30

13.19 -0.03 -0.20%

After hours · Oct 30, 7:37 PM ET

Bid
13.21 × 2
Ask
13.22 × 2
13.19 Day range 13.60
12.76 52-week range 16.62
YTD
-10.01%
1 year
-10.13%
Open
13.60
Prev close
13.51
Mkt cap
760.73M
Vol
439.91K
Avg vol
465.98K
EPS
1.21
P/E
10.93
Div yield
0.00%
More statistics
Low
13.19
High
13.60
Forward P/E
7.35
Beta
2.09
Short ratio
3.99
Inst. own
56.97%
Dividend
0.00
Ex-div date
50-d avg
14.95
200-d avg
15.70
1y target
16.65

5D chart

Chart tools
Interval

Signals (57)
NameTimeAgo
MACD: Buy SignalOct 28, 3:55 PM3 days ago
SMA: BullishOct 28, 3:40 PM3 days ago
SMA: BearishOct 28, 2:45 PM3 days ago
MACD: Sell SignalOct 28, 1:55 PM3 days ago
SMA: BullishOct 28, 11:55 AM3 days ago
SMA: BearishOct 28, 11:50 AM3 days ago
MACD: Buy SignalOct 28, 11:30 AM3 days ago
RSI: OversoldOct 28, 10:00 AM3 days ago
RSI: OversoldOct 28, 9:40 AM3 days ago
MACD: Sell SignalOct 27, 2:25 PM4 days ago
SMA: BearishOct 27, 2:15 PM4 days ago
SMA: BearishOct 27, 1:50 PM4 days ago
SMA: BullishOct 27, 1:45 PM4 days ago
SMA: BullishOct 27, 12:50 PM4 days ago
SMA: BearishOct 27, 12:45 PM4 days ago
MACD: Buy SignalOct 27, 12:00 PM4 days ago
SMA: BullishOct 27, 11:50 AM4 days ago
MACD: Sell SignalOct 27, 11:05 AM4 days ago
SMA: BullishOct 27, 10:30 AM4 days ago
MACD: Buy SignalOct 27, 10:30 AM4 days ago
MACD: Sell SignalOct 27, 10:25 AM4 days ago
SMA: BearishOct 27, 10:15 AM4 days ago
MACD: Buy SignalOct 27, 10:10 AM4 days ago
SMA: BullishOct 27, 10:05 AM4 days ago
SMA: BearishOct 27, 9:55 AM4 days ago
SMA: BearishOct 27, 9:55 AM4 days ago
SMA: BullishOct 27, 9:50 AM4 days ago
SMA: BullishOct 27, 9:50 AM4 days ago
MACD: Sell SignalOct 27, 9:35 AM4 days ago
SMA: BearishOct 26, 3:40 PM5 days ago
SMA: BullishOct 26, 2:40 PM5 days ago
MACD: Buy SignalOct 26, 2:40 PM5 days ago
RSI: OversoldOct 26, 12:40 PM5 days ago
SMA: BullishOct 26, 12:05 PM5 days ago
MACD: Sell SignalOct 26, 11:45 AM5 days ago
SMA: BearishOct 26, 11:25 AM5 days ago
SMA: BullishOct 26, 11:10 AM5 days ago
SMA: BullishOct 26, 11:10 AM5 days ago
MACD: Buy SignalOct 26, 10:15 AM5 days ago
SMA: BullishOct 26, 10:10 AM5 days ago
RSI: OversoldOct 26, 9:30 AM5 days ago
MACD: Sell SignalOct 23, 1:45 PM1 week ago
MACD: Buy SignalOct 23, 1:25 PM1 week ago
MACD: Sell SignalOct 23, 12:50 PM1 week ago
SMA: BearishOct 23, 12:20 PM1 week ago
MACD: Buy SignalOct 23, 10:45 AM1 week ago
SMA: BearishOct 23, 10:35 AM1 week ago
RSI: OversoldOct 23, 9:30 AM1 week ago
SMA: BearishOct 22, 3:55 PM1 week ago
MACD: Sell SignalOct 22, 3:55 PM1 week ago
SMA: BullishOct 22, 1:55 PM1 week ago
SMA: BearishOct 22, 1:50 PM1 week ago
MACD: Buy SignalOct 22, 1:45 PM1 week ago
SMA: BullishOct 22, 1:30 PM1 week ago
SMA: BearishOct 22, 12:00 PM1 week ago
RSI: OverboughtOct 22, 11:30 AM1 week ago
RSI: OverboughtOct 22, 11:10 AM1 week ago

Key statistics

Market cap
985.43M
Enterprise value
508.08M
Trailing P/E
6.55
Forward P/E
7.35
PEG ratio
0.00
Price / sales
2.45
Price / book
1.57
EPS (TTM)
2.38
Beta
2.09
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
44.50%
Revenue (TTM)
401.56M
Revenue growth
10.60%
Free cash flow
39.67M
Total cash
510.68M
Total debt
6.10M
Return on equity
25.91%
Shares outstanding
63.21M
Short % of float
5.33%
50-day average
14.95
200-day average
15.70

Analyst view

Consensus: hold

Hold
Price target (mean) 16.65 +25.9% upside
Target (low)
14.00
Target (mean)
16.65
Target (high)
21.00
Ratings (0m) 7 1 buy · 6 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold6
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate 0.35499.

Earnings history

Financials — quick view

All financials
INMD Revenue — quarterly 95.59M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
INMD Net income — quarterly 17.06M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
INMD EPS — quarterly 0.29
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

INMD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2025Sep 1, 2025—0.38——
Jul 30, 2025Jun 1, 20250.430.47+0.04+9.30%
Apr 28, 2025Mar 1, 20250.330.31-0.02-6.06%
Feb 4, 2025Dec 1, 20240.500.42-0.08-16.00%
Oct 30, 2024Sep 1, 20240.570.70+0.13+22.81%

Upgrades / downgrades

INMD analyst upgrades and downgrades
DateFirmActionFromTo
Oct 10, 2025Canaccord GenuitymainHoldHold
Oct 10, 2025NeedhamreitHoldHold
Jul 30, 2025NeedhamreitHoldHold
Jul 30, 2025BarclaysmainOverweightOverweight
Jul 11, 2025Canaccord GenuitymainHoldHold
Apr 30, 2025BarclaysmainOverweightOverweight

About InMode Ltd.

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.

Sector
Healthcare
Industry
Medical Devices
Country
Israel
Website
inmodemd.com

News

Your note

Sign in to keep a note on INMD — it syncs with the Stock Master app.

Institution ownership

INMD institution ownership
Holder% heldSharesValueReported
Renaissance Technologies, LLC3.68%2,326,51836.27MJun 29, 2025
Blackrock Inc.3.63%2,294,73235.77MJun 29, 2025
Doma Perpetual Capital Management LLC3.54%2,239,32334.91MJun 29, 2025
LSV Asset Management3.07%1,939,06730.23MJun 29, 2025
Meitav Investment House Ltd.2.09%1,323,20520.63MJun 29, 2025
Millennium Management Llc1.95%1,233,06519.22MJun 29, 2025

Fund ownership

INMD fund ownership
Holder% heldSharesValueReported
Boston Trust Walden Funds-Boston Trust Walden Small Cap Fund0.86%546,3998.52MJun 29, 2025
iShares Trust-iShares Core MSCI EAFE ETF0.77%487,0787.59MAug 30, 2025
JPMorgan Trust I-JPMorgan Small Cap Blend Fund0.53%338,0945.27MJun 29, 2025
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund0.52%329,5095.14MMay 30, 2025
HOTCHKIS & WILEY Fd.S/DE/-Hotchkis & Wiley Small Cap Diversified Value0.30%187,8002.93MJun 29, 2025
iShares Trust-iShares Core MSCI Total International Stock ETF0.29%185,0682.89MAug 30, 2025
Advertisement